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Abstract
Introduction: Vitamin	D	 deficiency	 is	 common	 in	 spinal	 surgery	 and	 critical	 care.	
Hypovitaminosis D may impact on outcomes in cranial neurosurgical care and play 
roles in underlying disease processes.
Methods: A	prospective	observational	cohort	study	was	performed.	All	emergency	
cranial neurosurgical ward admissions from 1st January to 10th May 2017 were 
screened for inclusion (n = 406). Patients already receiving vitamin D supplemen-
tation,	 spinal	 patients	 and	 elective	 admissions	 were	 excluded.	 Admission	 vitamin	
D	 levels	were	checked	 for	all	 remaining	patients	 (n	=	95).	Patients	with	vitamin	D	
<30	nmol/L	were	defined	as	“deficient”	and	those	30-50	nmol/L	as	“inadequate.”	All	
patients	with	 levels	<50	nmol/L	were	replaced,	as	per	 local	guidelines.	Descriptive	
analyses	of	the	cohorts	were	undertaken,	with	multivariate	regression	used	to	assess	
the	effect	of	vitamin	D	on	length	of	stay,	inpatient	morbidity	and	mortality.
Results: The	median	age	of	participants	was	61	years	(n	=	95;	57%	male,	43%	female).	
The	median	vitamin	D	level	was	23	nmol/L	(deficient).	84%	(n	=	80)	of	patients	had	
low	vitamin	D	 levels,	with	61%	 (n	=	58)	classed	as	deficient	 (<30	nmol/L).	Vitamin	
D	deficiency	rates	were	similar	in	those	aged	below	65	years	(86%;	n	=	38/44)	and	
those	above	65	years	(82%;	n	=	42/51).	Deficient	vitamin	D	level	was	associated	with	
longer hospital stay (P	=	.03),	and	this	relationship	persisted	after	adjusting	for	po-
tential	confounders	such	as	age,	sex	and	preadmission	Charlson	co-morbidity	index.	
No	statistically	significant	association	was	seen	with	vitamin	D	status	and	inpatient	
morbidity or mortality.
Conclusions: Vitamin	D	deficiency	is	common	in	cranial	neurosurgical	patients,	even	
in	predefined	low-risk	groups	(age	<65).	Lower	vitamin	D	level	was	associated	with	
longer length of stay. This study supports the need for: (a) further investigation into 
the roles of vitamin D in neurosurgical pathologies and management and (b) an ap-
propriately	powered,	randomised	 investigation	 into	the	 impact	of	vitamin	D	status	
upon neurosurgical diagnoses and complications.
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1  | INTRODUC TION
Vitamin	D	deficiency	 is	common,	with	 low	 levels	 thought	 to	be	as	
prevalent	as	40%-60%	in	patient	groups	with	risk	factors	for	vitamin	
D deficiency.1	 These	 risk	 factors	 include	 being	 over	 65	 years	 old,	
frailty,	body	weight,	systemic	co-morbidities,	skin	pigmentation	and	
reduced	sun	exposure.	These	patient	groups	commonly	present	to	
neurosurgical	units	with	cranial	pathology.	Vitamin	D	deficiency	has	
also been associated with adverse outcomes in neurocritical care 
settings1,2 and spinal surgery.3	Vitamin	D	deficiency	could	therefore	
impact on complications and outcomes in neurosurgical care and 
may even play roles in underlying disease processes. This is because 
vitamin	D	is	thought	to	play	key	roles	in	tissue	homeostasis,	wound	
healing,	neurone	function	and,	potentially,	neuroinflammation.4,5
Studies	 have	 identified	 that	 supplementation	 of	 vitamin	 D	 to	
inpatients with hypovitaminosis D can reduce mortality and mor-
bidity.6	These	works	have	focussed	on	specific	patient	populations,	
such	 as	 spinal	 surgery,	 medical	 patients	 and	 critical	 care	 units.1,2 
However,	the	prevalence	of	hypovitaminosis	D	in	cranial	neurosur-
gical	 patients	 at	 a	ward-based	 level	 remains	 unclear.	 It	 is	 also	 un-
certain	whether	low	vitamin	D	might	be	an	independent	risk	factor	
for	mortality,	morbidity	and	other	poor	outcomes	in	these	patients.	
This study prospectively assessed the prevalence of hypovitamino-
sis D in cranial neurosurgical ward patients admitted over the winter 
months	to	a	tertiary	neurosurgical	unit.	This	work	also	studied	the	
association between low vitamin D levels in these patients and clin-
ical	outcomes	such	as	mortality,	length	of	stay,	inpatient	morbidity	
and patient disability at discharge.
2  | MATERIAL S AND METHODS
Figure 1 describes the methodology of this prospective cohort 
study.	All	patients	admitted	to	a	single	neurosurgical	unit	at	ward-
level	 were	 screened	 for	 inclusion.	 Serum	 25-hydroxy	 vitamin	 D	
concentrations	 were	 taken	 from	 eligible	 adult	 patients	 admitted	
for	 cranial	 neurosurgical	 pathologies,	 such	 as	 debulking	 of	 cranial	
tumours,	 cerebrovascular	events,	 traumatic	brain	 injuries,	 cerebral	
abscesses	 and	 hydrocephalus.	 Admission	 vitamin	 D	 levels	 were	
classified	using	Institute	of	Medicine	(IOM)	international	reference	
ranges.7	Vitamin	D	 levels	>50	nmol/L	were	defined	as	“sufficient.”	
Levels	30-50	nmol/L	were	defined	as	“inadequate.”	Vitamin	D	levels	
<30	nmol/L	were	defined	as	“deficient.”	Those	found	to	have	a	level	
<50	nmol/L	(inadequate	or	deficient)	received	replacement	therapy,	
as	 per	 local	 public	 health	 guidelines,	 with	 oral	 vitamin	 D	 supple-
ments	(Stexerol	(Colecalciferol)	1000	unit	tablets;	4000	units	daily	
for	10	weeks	then	1000	units	daily).8 The data were collected and 
analysed as described in Figure 1.
Vitamin	D	levels	are	known	to	fluctuate	with	seasonal	variations	
in sunlight.4	To	avoid	this	variability	confounding	the	study	results,	
the	study	was	conducted	over	a	single	season,	(winter)	such	that	re-
gional sunlight levels were relatively constant during the time span 
of the study.
Statistical	analyses	were	completed	using	descriptive	statistics,	
and	multivariate	logistical	regression	analysis	using	SPPS© software. 
A	normal	distribution	was	approximated	using	a	log	transformation,	
to	permit	linear	regression	analysis,	which	permitted	adjusted	anal-
yses	for	suspected	confounding	variables	(eg	age,	Charlson	Co-mor-
bidity	index).
3  | RESULTS
Of	 the	 95	 patients	who	met	 the	 inclusion	 criteria,	 54	 (57%)	were	
male	and	41	(43%)	were	female,	with	a	median	age	being	61	years	
(18-94	 years).	 The	 median	 vitamin	 D	 level	 was	 23	 nmol/L	 (range	
10-89	 nmol/L),	 which	 is	 deficient.	 80	 patients	 (84%)	 had	 vitamin	
D	<50	nmol/L,	necessitating	treatment.	Vitamin	D	deficiency	rates	
were	similar	in	those	aged	below	65	years	(86%;	n	=	38/44)	and	those	
above	65	years	(82%;	n	=	42/51),	despite	older	age	being	a	risk	factor	
for	vitamin	D	deficiency.	No	patients	in	the	study	cohort	were	taking	
any vitamin D supplements prior to admission to hospital Figure 1.
Table	 S1	 (see	 Supplementary	 data)	 outlines	 demographic	 fea-
tures	 and	 clinical	 outcomes	 of	 the	 study	 population.	 Key	 points	
F I G U R E  1   Flowchart outlining the 
study methodology
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include	 that	 61%	 (n	 =	 58)	 of	 patients	 were	 identified	 to	 be	 defi-
cient	 (<30	nmol/L)	 in	vitamin	D	 levels.	 “Inpatient	morbidity”	refers	
to	 complications	 such	as	 systemic	 infection,	wound	dehiscence	or	
infection,	thromboembolism,	recollection	of	the	original	pathology	
or	other	noninfective	medical	complications.	Of	the	38	patients	 in	
this subcohort who developed at least one of these issues whilst an 
inpatient,	33	(87%)	presented	with	inadequate	or	deficient	vitamin	D	
levels.	Other	markers	of	inpatient	outcomes,	such	as	length	of	stay,	
return to theatre and disability score at discharge (assessed via the 
modified	Rankin	Scale)	all	 identified	higher	proportions	of	patients	
with worse outcomes in the hypovitaminosis D group. There was no 
statistically significant difference in mortality between vitamin D re-
plete	(n	=	2/15;	13%)	and	vitamin	D	deficient	(n	=	5/80;	6%)	patients.
Figure 2 illustrates that the majority of patients in the study co-
hort	had	a	suboptimal	vitamin	D	level	on	admission.	Figure	3	outlines	
the	distribution	of	cranial	pathologies	amongst	patients	in	the	study,	
and	 that	 hypovitaminosis	D	was	more	 common	 than	 adequate	 vi-
tamin D levels across the entire range of neurosurgical pathologies 
studied,	such	as	patients	with	neurovascular	conditions	(SAH),	neu-
rotrauma and intracranial neoplasms or infections.
Figure 4 highlights the effect of vitamin D levels on length of 
inpatient	 stay	 in	 the	 neurosurgical	 unit.	 A	 median	 length	 of	 stay	
of	13	days	was	identified	in	patients	with	a	normal	vitamin	D	level	
(range	=	3-22	days).	The	median	length	of	stay	for	patients	with	de-
ficient	or	 inadequate	vitamin	D	 levels	was	16	days	 (range	=	8-26).	
This	difference	reached	statistical	significance,	even	after	adjusting	
analyses	for	age,	sex,	ethnicity	and	admission	Charlson	co-morbid-
ity	index	(P	=	.03).	There	was	no	statistically	significant	correlation	
between	vitamin	D	and	patient	mortality	rates,	inpatient	morbidity	
or	a	patient's	discharge	modified	Rankin	scale.
4  | DISCUSSION
To	our	knowledge,	this	is	the	first	study	to	review	the	prevalence	of	
vitamin D levels in cranial neurosurgical ward patients and assess 
their clinical outcomes. Hypovitaminosis D was common through-
out	the	cohort,	with	a	prevalence	of	84%,	with	a	prevalence	in	the	
younger	subcohort	of	86%.	By	contrast,	the	prevalence	of	hypovi-
taminosis	 D	 in	 young,	 healthy	 populations	 is	 approximately	 36%9 
and	50%-70%	of	acutely	unwell	patients.2,10 Hypovitaminosis D may 
therefore be more common in neurosurgical patients compared to 
healthy adults and patients with other systemic pathologies.
Despite	many	different	risk	factors	affecting	vitamin	D	levels,1,3 
its statistically significant correlation with length of hospital stay 
was still observed when statistical adjustments for potential con-
founders,	 such	 as	 patient	 age,	 ethnicity	 and	 co-morbidities,	 were	
performed.	Thus,	 the	effects	of	vitamin	D	deficiency	on	 length	of	
stay	 identified	 in	 this	cohort	may	be	a	genuine	effect,	being	 inde-
pendent	 of	 the	 analysed	 potential	 confounding	 factors.	 However,	
caution is needed in interpretating these results due to possibility of 
residual confounding.
Whilst	 previous	 works	 have	 not	 found	 significant	 correlations	
between	hypovitaminosis	D	and	length	of	ward	stay,11 these small 
studies	 focussed	on	 general	 surgical	 patients,	 and	 therefore	 it	 re-
mains	plausible	that	vitamin	D	deficiency	may	be	of	key	significance	
F I G U R E  2  Histogram	of	vitamin	D	levels	on	admission.	The	majority	of	patients	in	the	cohort	had	inadequate	(30-50	nmol/L)	or	deficient	
(<30	nmol/L)	vitamin	D	level	on	admission
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in neurosurgical patients. The increased length of hospital stay could 
have	 significant	 economic	 repercussions,	with	 an	 average	hospital	
bed	 in	 recovery	after	high	risk	operation,	such	as	neurosurgery	or	
cardiac	surgery,	costing	between	£300	and	£700	per	day.12-14
Vitamin	D	 did	 not	 have	 any	 statistically	 significant	 correlation	
with	patient	mortality	or	morbidity.	In	the	neurocritical	care	setting,	
associations between hypovitaminosis D and increased mortality 
and morbidity have been demonstrated.1,6 These studies involved 
larger	cohorts	of	intensive	care	patients,	and	it	 is	possible	that	the	
present study was underpowered to detect significant differences in 
mortality or morbidity between the vitamin D deficient and nonde-
ficient	groups.	However,	it	is	also	possible	that	vitamin	D	takes	on	a	
greater role in promoting convalescence and recovery in critically ill 
patients,	who	have	severe,	multisystemic	pathologies.15
There is mounting evidence that vitamin D may play important 
roles	in	the	nervous	system,	from	neurodevelopment	in	animal	mod-
els,	adult	neuronal	metabolic	activity	and	potential	mediating	effects	
on	 neurotrophic	 factors	 and,	 hence,	 neuronal	 recovery.16	 It	 is	 also	
known	that	vitamin	D	has	a	role	in	systemic	and	neuroinflammatory	
responses,	both	directly	and	indirectly	influencing	a	variety	of	immune	
cells.17	Vitamin	D	deficiency	may	therefore	have	important	functions	
in	 recovery	 and	 repair	 after	 brain	 injury,	 but	 also	potentially	 in	 the	
pathogenesis of neurosurgical diseases related to neuroinflammation.
The present study has a relatively small sample size. The nature 
of	the	variable	studied	(vitamin	D)	means	there	is	a	high	risk	of	con-
founding in the identified associations. This limits the power of our 
study	to	detect	differences	in	patient	length	of	stay,	morbidity	and	
mortality. The relatively ethnically homogenous study group and 
the	single-centre	study	design	also	 limit	 the	generalisability	of	 the	
study findings.4	Furthermore,	the	study	was	conducted	over	winter	
months	 in	a	centre-based	 in	 the	Northern	hemisphere,	when	vita-
min	D	levels	in	the	general	population	are	known	to	reach	a	nadir.5 
F I G U R E  3   The distribution of vitamin D deficiency amongst varying pathologies in the study cohort. The majority of patients with 
emergency	neurosurgical	conditions	were	identified	to	have	low	vitamin	D	levels.	ASDH,	Acute	subdural	haematoma;	CSDH,	Chronic	
subdural	haematoma;	EDH,	Extradural	haematoma;	ICH,	intracerebral	haemorrhage;	SAH,	Subarachnoid	haemorrhage;	SOL,	space	
occupying	lesion;	TBI,	traumatic	brain	injury
F I G U R E  4  Box	plot	showing	the	effect	of	vitamin	D	on	the	
median	length	of	stay	(LOS).	Low	(inadequate	or	deficient)	vitamin	
D	was	significantly	associated	with	a	longer	inpatient	LOS	in	the	
neurosurgical unit compared to vitamin D replete patients (16 days 
Vs	13	days).	Normal	vitamin	D:	serum	25-hydroxy	vitamin	D	>50	
nmol/L.	Inadequate	or	deficient	(low)	vitamin	D:	serum	25hydroxy	
vitamin	D	≤50	nmol/L.	LOS,	length	of	stay
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However,	 this	 design	 ensured	 that	 seasonal	 variation	 in	 baseline	
vitamin	D	level	was	not	a	confounding	factor	 in	the	present	work;	
there remains a need to continue this investigation during summer 
months. This would assess whether the prevalence and impact of hy-
povitaminosis D varies by season for the study population. Further 
investigations	using	pooled	data	from	multiple	neurosurgical	units,	
possible from similar latitudes to avoid seasonal confounding of vi-
tamin	D	 levels,	would	 improve	the	power	of	a	study	assessing	the	
effects of hypovitaminosis D on neurosurgery patients.
Another	factor	to	consider	is	that	vitamin	D	binding	protein	may	
act as a negative acute phase reactant in systemic illness and in-
flammatory	states,	 thereby	correlating	with	 low	serum	vitamin	D	
levels.18 This was mitigated by ensuring all patients in our study had 
their	vitamin	D	 levels	drawn	prior	 to	any	surgery,	and	none	were	
critically	unwell	such	as	to	require	level	3	intensive	care.	Measuring	
levels	 of	 VDBP	 may	 be	 advisable	 in	 future	 studies,	 to	 identify	
whether it influences vitamin D levels in neurosurgical patients.
We	were	duty-bound	to	treat	patients	who	had	vitamin	D	de-
ficiency diagnosed on admission to the unit. Whilst this has the 
potential	 to	bias	 the	 study's	 conclusions,	 it	would	 tend	 to	do	 so	
towards the null hypothesis.6	 Therefore,	 the	 true	 effects	 of	 hy-
povitaminosis D on neurosurgery patients may be even more pro-
nounced	 than	 that	 reported	 in	 the	 present	 study.	A	 comparison	
of	long-term	outcomes	in	patients	with	normal	and	low	vitamin	D	
on	 neurosurgical	 admission	 remains	 to	 be	 completed,	 and	 there	
may be value in comparing the prevalence of vitamin D deficiency 
in	our	patient	population	with	its	prevalence	in	our	local,	healthy	
population. The need for a randomised study to assess the impact 
of	vitamin	D	supplementation	in	neurosurgery,	which	could	review	
factors	 such	 as	 patient	 length	 of	 stay,	 morbidity	 and	 mortality	
verses	a	placebo	arm,	should	be	considered.
In	 conclusion,	 vitamin	 D	 deficiency	 is	 common	 in	 neurosur-
gical	patients,	even	 in	predefined	“low	risk”	groups	 (eg	age	<65).	
Lengths	of	stay	for	patients	who	were	deficient	were	prolonged.	
A	 key	 limitation	 of	 this	 study	 is	 the	 high	 risk	 of	 confounding	 or	
residual	 confounding;	 therefore,	 it	 remains	 to	 be	 seen	 whether	
immediate supplementation would bring with it clinical benefits. 
Furthermore,	a	small	number	of	patients	in	the	study	cohort	had	
particularly	 long	stays,	which	 increases	the	risk	of	a	spurious	as-
sociation	being	identified.	However,	given	the	widespread	effects	
of	vitamin	D	on	numerous	body	systems,	the	possibility	of	a	true	
impact of vitamin D deficiency on clinical outcomes seems plau-
sible.	Therefore,	this	data	supports	further	investigation	into	the	
role of vitamin D in neurosurgical pathological mechanisms and 
management,	as	well	as	an	appropriately	powered,	randomised	in-
vestigation into the impact of vitamin D status upon neurosurgical 
diagnoses,	complications	and	clinical	outcomes.
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